{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:57:55Z","timestamp":1775739475432,"version":"3.50.1"},"reference-count":59,"publisher":"Baishideng Publishing Group Inc.","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.2472","type":"journal-article","created":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T04:11:27Z","timestamp":1243397487000},"page":"2472","source":"Crossref","is-referenced-by-count":36,"title":["Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies"],"prefix":"10.3748","volume":"15","author":[{"given":"Massimo C","family":"Fantini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Monteleone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N, Ozden A, Duman M. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int 2006;26:663-668.","DOI":"10.1007\/s00296-005-0044-9"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppala K. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum 1994;37:23-31.","DOI":"10.1002\/art.1780370105"},{"key":"ref3","unstructured":"Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, Schatteman L, Gyselbrecht L, Elewaut D. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 1995;22:2279-2284."},{"key":"ref4","unstructured":"Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, Schatteman L, Elewaut D. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 1995;22:2273-2278."},{"key":"ref5","unstructured":"Mielants H, Veys EM, De Vos M, Cuvelier C, Goemaere S, De Clercq L, Schatteman L, Elewaut D. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 1995;22:2266-2272."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434.","DOI":"10.1038\/nature06005"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Sartor RB, Muehlbauer M. Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr Gastroenterol Rep 2007;9:497-507.","DOI":"10.1007\/s11894-007-0066-4"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Campbell DJ, Butcher EC. Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J Exp Med 2002;195:135-141.","DOI":"10.1084\/jem.20011502"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hasslen SR, Nelson RD, Berg EL, Erlandsen SL, Butcher EC. alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995;80:413-422.","DOI":"10.1016\/0092-8674(95)90491-3"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Berlin C, Berg EL, Briskin MJ, Andrew DP, Kilshaw PJ, Holzmann B, Weissman IL, Hamann A, Butcher EC. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993;74:185-195.","DOI":"10.1016\/0092-8674(93)90305-A"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Souza HS, Elia CC, Spencer J, MacDonald TT. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7\/MAdCAM-1 and OX40\/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut 1999;45:856-863.","DOI":"10.1136\/gut.45.6.856"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Stenstad H, Ericsson A, Johansson-Lindbom B, Svensson M, Marsal J, Mack M, Picarella D, Soler D, Marquez G, Briskin M. Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine. Blood 2006;107:3447-3454.","DOI":"10.1182\/blood-2005-07-2860"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Johansson-Lindbom B, Svensson M, Wurbel MA, Malissen B, Marquez G, Agace W. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med 2003;198:963-969.","DOI":"10.1084\/jem.20031244"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Salmi M, Jalkanen S. Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD. Inflamm Bowel Dis 1998;4:149-156.","DOI":"10.1097\/00054725-199805000-00026"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Salmi M, Andrew DP, Butcher EC, Jalkanen S. Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms. J Exp Med 1995;181:137-149.","DOI":"10.1084\/jem.181.1.137"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Salmi M, Rajala P, Jalkanen S. Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. J Clin Invest 1997;99:2165-2172.","DOI":"10.1172\/JCI119389"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Salmi M, Jalkanen S. Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J Immunol 2001;166:4650-4657.","DOI":"10.4049\/jimmunol.166.7.4650"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, Balish E, Hammer RE. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-2364.","DOI":"10.1084\/jem.180.6.2359"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Rath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun 1999;67:2969-2974.","DOI":"10.1128\/IAI.67.6.2969-2974.1999"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE Jr, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27\/human beta2 microglobulin transgenic rats. J Clin Invest 1996;98:945-953.","DOI":"10.1172\/JCI118878"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Hammer M, Zeidler H, Klimsa S, Heesemann J. Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis. Arthritis Rheum 1990;33:1795-1800.","DOI":"10.1002\/art.1780331206"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Granfors K, Jalkanen S, Lindberg AA, Maki-Ikola O, von Essen R, Lahesmaa-Rantala R, Isomaki H, Saario R, Arnold WJ, Toivanen A. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990;335:685-688.","DOI":"10.1016\/0140-6736(90)90804-E"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Granfors K, Jalkanen S, von Essen R, Lahesmaa-Rantala R, Isomaki O, Pekkola-Heino K, Merilahti-Palo R, Saario R, Isomaki H, Toivanen A. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989;320:216-221.","DOI":"10.1056\/NEJM198901263200404"},{"key":"ref24","unstructured":"Purrmann J, Zeidler H, Bertrams J, Juli E, Cleveland S, Berges W, Gemsa R, Specker C, Reis HE. HLA antigens in ankylosing spondylitis associated with Crohn&lsquo;s disease. Increased frequency of the HLA phenotype B27,B44. J Rheumatol 1988;15:1658-1661."},{"key":"ref25","unstructured":"Palm O, Moum B, Ongre A, Gran JT. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol 2002;29:511-515."},{"key":"ref26","unstructured":"de Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 2000;27:2860-2865."},{"key":"ref27","unstructured":"Steer S, Jones H, Hibbert J, Kondeatis E, Vaughan R, Sanderson J, Gibson T. Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn&rsquo;s disease. J Rheumatol 2003;30:518-522."},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Kuon W, Sieper J. Identification of HLA-B27-restricted peptides in reactive arthritis and other spondyloarthropathies: computer algorithms and fluorescent activated cell sorting analysis as tools for hunting of HLA-B27-restricted chlamydial and autologous crossreactive peptides involved in reactive arthritis and ankylosing spondylitis. Rheum Dis Clin North Am 2003;29:595-611.","DOI":"10.1016\/S0889-857X(03)00050-4"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Mertz AK, Wu P, Sturniolo T, Stoll D, Rudwaleit M, Lauster R, Braun J, Sieper J. Multispecific CD4+ T cell response to a single 12-mer epitope of the immunodominant heat-shock protein 60 of Yersinia enterocolitica in Yersinia-triggered reactive arthritis: overlap with the B27-restricted CD8 epitope, functional properties, and epitope presentation by multiple DR alleles. J Immunol 2000;164:1529-1537.","DOI":"10.4049\/jimmunol.164.3.1529"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Thiel A, Wu P, Lauster R, Braun J, Radbruch A, Sieper J. Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry. Arthritis Rheum 2000;43:2834-2842.","DOI":"10.1002\/1529-0131(200012)43:12<2834::AID-ANR25>3.0.CO;2-7"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Scofield RH, Kurien B, Gross T, Warren WL, Harley JB. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet 1995;345:1542-1544.","DOI":"10.1016\/S0140-6736(95)91089-1"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Ramos M, Alvarez I, Sesma L, Logean A, Rognan D, Lopez de Castro JA. Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins. J Biol Chem 2002;277:37573-37581.","DOI":"10.1074\/jbc.M205470200"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Torok HP, Glas J, Gruber R, Brumberger V, Strasser C, Kellner H, Marker-Hermann E, Folwaczny C. Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion 2004;70:49-54.","DOI":"10.1159\/000080081"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Cohavy O, Bruckner D, Gordon LK, Misra R, Wei B, Eggena ME, Targan SR, Braun J. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun 2000;68:1542-1548.","DOI":"10.1128\/IAI.68.3.1542-1548.2000"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Pamer E, Cresswell P. Mechanisms of MHC class I--restricted antigen processing. Annu Rev Immunol 1998;16:323-358.","DOI":"10.1146\/annurev.immunol.16.1.323"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Mear JP, Schreiber KL, Munz C, Zhu X, Stevanovic S, Rammensee HG, Rowland-Jones SL, Colbert RA. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol 1999;163:6665-6670.","DOI":"10.4049\/jimmunol.163.12.6665"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Pahl HL, Sester M, Burgert HG, Baeuerle PA. Activation of transcription factor NF-kappaB by the adenovirus E3\/19K protein requires its ER retention. J Cell Biol 1996;132:511-522.","DOI":"10.1083\/jcb.132.4.511"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Tran TM, Dorris ML, Satumtira N, Richardson JA, Hammer RE, Shang J, Taurog JD. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis Rheum 2006;54:1317-1327.","DOI":"10.1002\/art.21740"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Kollnberger S, Bird LA, Roddis M, Hacquard-Bouder C, Kubagawa H, Bodmer HC, Breban M, McMichael AJ, Bowness P. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 2004;173:1699-1710.","DOI":"10.4049\/jimmunol.173.3.1699"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Uchanska-Ziegler B, Ziegler A. Ankylosing spondylitis: a beta2m-deposition disease? Trends Immunol 2003;24:73-76.","DOI":"10.1016\/S1471-4906(02)00028-5"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-238.","DOI":"10.1038\/nature04753"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Mangan PR, Harrington LE, O&rsquo;Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006;441:231-234.","DOI":"10.1038\/nature04754"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006;116:1310-1316.","DOI":"10.1172\/JCI21404"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, Fick RB, Kastelein RA. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 2007;132:2359-2370.","DOI":"10.1053\/j.gastro.2007.03.104"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Fina D, Sarra M, Fantini MC, Rizzo A, Caruso R, Caprioli F, Stolfi C, Cardolini I, Dottori M, Boirivant M. Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology 2008;134:1038-1048.","DOI":"10.1053\/j.gastro.2008.01.041"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, Pfennig S, Jurgens M, Schmechel S, Konrad A. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008;14:437-445.","DOI":"10.1002\/ibd.20339"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Jandus C, Bioley G, Rivals JP, Dudler J, Speiser D, Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 2008;58:2307-2317.","DOI":"10.1002\/art.23655"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Wendling D, Cedoz JP, Racadot E, Dumoulin G. Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine 2007;74:304-305.","DOI":"10.1016\/j.jbspin.2006.11.005"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-1463.","DOI":"10.1126\/science.1135245"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum 2008;58:1020-1025.","DOI":"10.1002\/art.23389"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999;10:387-398.","DOI":"10.1016\/S1074-7613(00)80038-2"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Armaka M, Apostolaki M, Jacques P, Kontoyiannis DL, Elewaut D, Kollias G. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J Exp Med 2008;205:331-337.","DOI":"10.1084\/jem.20070906"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Van den Bosch F, Kruithof E, De Vos M, De Keyser F, Mielants H. Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet 2000;356:1821-1822.","DOI":"10.1016\/S0140-6736(00)03239-6"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Van Den Bosch F, Kruithof E, Baeten D, Herssens A, de Keyser F, Mielants H, Veys EM. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. Arthritis Rheum 2002;46:755-765.","DOI":"10.1002\/art.511"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359:1187-1193.","DOI":"10.1016\/S0140-6736(02)08215-6"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Generini S, Giacomelli R, Fedi R, Fulminis A, Pignone A, Frieri G, Del Rosso A, Viscido A, Galletti B, Fazzi M. Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations. Ann Rheum Dis 2004;63:1664-1669.","DOI":"10.1136\/ard.2003.012450"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Braun J, Baraliakos X, Listing J, Davis J, van der Heijde D, Haibel H, Rudwaleit M, Sieper J. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Arthritis Rheum 2007;57:639-6347.","DOI":"10.1002\/art.22669"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, Dougados M, Reveille JD, Wong RL, Kupper H. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006;54:2136-2146.","DOI":"10.1002\/art.21913"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"van der Heijde D, Schiff MH, Sieper J, Kivitz AJ, Wong RL, Kupper H, Dijkmans BA, Mease PJ, Davis JC Jr. Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial. Ann Rheum Dis 2009;68:922-929.","DOI":"10.1136\/ard.2007.087270"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i20\/2472.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T09:51:46Z","timestamp":1685008306000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i20\/2472.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":59,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.2472","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}